J
Julio Garcia-Aguilar
Researcher at Memorial Sloan Kettering Cancer Center
Publications - 334
Citations - 18610
Julio Garcia-Aguilar is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Colorectal cancer & Cancer. The author has an hindex of 62, co-authored 289 publications receiving 14764 citations. Previous affiliations of Julio Garcia-Aguilar include Harvard University & University of San Francisco.
Papers
More filters
Journal ArticleDOI
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
Monique Maas,Patty J. Nelemans,Vincenzo Valentini,Prajnan Das,Claus Rödel,Li Jen Kuo,Felipe A. Calvo,Julio Garcia-Aguilar,Rob Glynne-Jones,Karin Haustermans,Mohammed Mohiuddin,Salvatore Pucciarelli,William Small,Javier Suárez,George Theodoropoulos,Sebastiano Biondo,Sebastiano Biondo,Regina G. H. Beets-Tan,Geerard L. Beets +18 more
TL;DR: Patients with pCR after chemoradiation have better long-term outcome than do those without pCR, and pCR might be indicative of a prognostically favourable biological tumour profile with less propensity for local or distant recurrence and improved survival.
Journal ArticleDOI
ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18).
Michael S. Diamond,Donald E. Staunton,A R de Fougerolles,Steven A. Stacker,Julio Garcia-Aguilar,Margaret L. Hibbs,Timothy A. Springer +6 more
TL;DR: It is concluded that ICAM-1 is a counter receptor for Mac-1 and that this receptor pair is responsible, in part, for the adhesion between stimulated neutrophils and stimulated endothelial cells.
Journal ArticleDOI
The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands.
Michael S. Diamond,Julio Garcia-Aguilar,Joanna K. Bickford,Angel L. Corbí,Timothy A. Springer +4 more
TL;DR: It is found that the alpha subunit NH2-terminal region and divalent cation binding region, despite being separated by over 200 amino acids of the I domain, appear structurally apposed because three mAbs require the presence of both of these regions for antigenic reactivity, and chimeras that contain the NH2 terminus of p150,95 require the divalentCation binding regions of p 150,95 to associate firmly with the beta subunit.
Journal ArticleDOI
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial
Julio Garcia-Aguilar,Oliver S. Chow,David D. Smith,Jorge E. Marcet,Peter A. Cataldo,Madhulika G. Varma,Anjali S. Kumar,Samuel Oommen,Theodore Coutsoftides,Steven R. Hunt,Michael J. Stamos,Charles A. Ternent,Daniel O. Herzig,Alessandro Fichera,Blase N. Polite,David W. Dietz,Sujata Patil,Karin Avila +17 more
TL;DR: Delivery of mFOLFOX6 after chemoradiation and before total mesorectal excision has the potential to increase the proportion of patients eligible for less invasive treatment strategies; this strategy is being tested in phase 3 clinical trials.
Journal ArticleDOI
Anal fistula surgery. Factors associated with recurrence and incontinence.
TL;DR: Surgical treatment of fistula-in-ano is associated with a significant risk of recurrence and a high risk of impaired continence and degree of risk varies with identifiable factors.